A Selective Direct Aldol Reaction Catalyzed by Zinc–Proline
FULL PAPER
(151 mg, 1.0 mmol) and HA (370 mg, 5.0 mmol), 9a could be iso-
(d, J = 6.6 Hz, 1 H), 7.55 (app. t, 1 H), 7,38 (app. t, 1 H), 5.48 (d,
J = 6.22 Hz, 1 H), 4.46 (d, J = 19.4 Hz, 1 H), 4.32 (d, J = 19.4 Hz,
lated after column chromatography (47 mg, 21%). 1H NMR
(CDCl3): δ = 8.25 (d, J = 8.3 Hz, 3 H), 7.67 (d, J = 8.3 Hz, 3 H), 1 H), 4.11 (d, J = 6.22 Hz, 1 H) ppm. 13C NMR (CD3OD): δ =
5.24 (d, J = 2.6 Hz, 1 H), 5.12 (d, 0.5 H, J = 4.7 Hz), 4.50 (d, 0.5 212.35, 138.13, 134.24, 130.65, 129.83, 125.45, 79.79, 71.86,
H, J = 4.7 Hz), 4.44 (d, J = 2.6 Hz, 1 H), 3.01 (br. s, 0.5 H), 2.83
68.60 ppm. HR ESI MS(+): calcd. for C10H11NNaO6 264.0484;
(br. s, 1 H), 2.39 (s, 3 H), 2.00 (s, 1.5 H) ppm. 13C NMR (CD3OD): found 264.0475. Anal. HPLC (254 nm; gradient 90% A, 10% D to
δ = 211.53, 129.27, 128.69, 124.05, 82.01, 74.53, 27.60, 26.00 ppm.
50% A, 50% D in 10 min): tR = 3.377 min.
3,4-Dihydroxy-4-(2-nitrophenyl)butan-2-one (9b) as a syn/anti Mix-
ture: According to the general procedure and starting from 1a
(151 mg, 1.0 mmol) and HA (370 mg, 5.0 mmol), 9b could be iso-
lated in low yield after column chromatography (8 mg, 4%) in a
syn/anti ratio of 1:0.6. 1H NMR (CDCl3): δ = 8.15–7.51 (several
4-(2-Bromophenyl)-1,3,4-trihydroxybutan-2-one (10c): Starting from
1c (185 mg, 1.0 mmol) and DHA (450 mg, 5.00 mmol), 10c was
obtained according to the general procedure with the following
modifications: the aqueous solution was lyophilized and the crude
product purified by preparative RP-HPLC to separate the two dia-
signals, 6.4 H), 5.92 (d, J = 1.3 Hz, 1 H), 5.56 (d, J = 6.2, 0.6 H), stereoisomers. syn-10c: Yield: 170 mg (62%), oil. IR (neat): ν =
˜
1
4.59 (s, J = 1.3 Hz, 1 H), 4.47 (d, J = 6.2 Hz, 0.6 H), 2.54 (s, 3 H),
2.20 (s, 1.8 H) ppm.
3253, 1734, 1468, 1439, 1103, 1066, 1022, 750, 654 cm–1. H NMR
(CD3OD): δ = 7.70 (d, J = 8.3 Hz, 1 H), 7.56 (d, J = 8.3 Hz, 1 H),
7.39 (app. t, 1 H), 7.16–7.21 (m, 1 H), 5.45 (d, J = 2.07 Hz, 1 H),
4.59 (s, 2 H), 4.41 (d, J = 2.07 Hz, 1 H) ppm. 13C NMR (CD3OD):
δ = 213.31, 142.09, 133.79, 131.35, 130.54, 128.72, 122.67, 79.00,
74.72, 68.44 ppm. HR ESI MS(+): calcd. for C10H11BrNaO4
296.9738; found 296.9749. Anal. HPLC (254 nm; gradient 90% A,
10% D to 50% A, 50% D in 10 min): tR = 4.963 min. anti-10c:
4-(2-Bromophenyl)-3,4-dihydroxybutan-2-one (9c): Starting from 1c
(185 mg, 1.0 mmol) and HA (370 mg, 5.0 mmol), 9c was obtained
according to the general procedure and with the following modifi-
cations: the aqueous solution was lyophilized and the crude prod-
uct purified by preparative RP-HPLC to separate the two dia-
stereoisomers. syn-9c: Yield: 70 mg (27%); oil. IR (neat): ν = 3379,
˜
Yield: 71 mg (26%), white solid, m.p. 66–69 °C. IR (neat): ν = 3282,
˜
1676, 1437, 1199, 1140, 845 cm–1. 1H NMR (CD3OD): δ = 7.73
(app. d, 1 H), 7.60 (app. d, 1 H), 7.43 (app. t, 1 H), 7.15–7.25 (m,
1 H), 5.50 (d, J = 1.69 Hz, 1 H), 4.38 (d, J = 1.69 Hz, 1 H), 2.40
(s, 3 H) ppm. 13C NMR (CD3OD): δ = 210.31, 143.19, 132.85,
130.37, 129.97, 128.36, 122.39, 79.29, 74.29, 29.75 ppm. HR ESI
MS(+): calcd. for C10H11BrNaO3 280.9789; found 280.9784. Anal.
RP-HPLC (254 nm, gradient 90% A, 10% D to 50% A, 50% D in
10 min): tR = 5.161 min. anti-9c: Yield: 16 mg (6%); white solid,
1722, 1464, 1369, 1323, 1188, 1074, 1018, 737 cm–1. 1H NMR
(CD3OD): δ = 7.50–7.77 (m, 2 H), 7.35 (app. t, 1 H), 7.1–7.2 (m,
1 H), 5.22 (d, J = 4.9 Hz, 1 H), 4.35–4.50 (m, 3 H) ppm. 13C NMR
(CD3OD): δ = 212.17, 141.69, 133.91, 130.66, 130.60, 128.86,
124.16, 79.47, 75.89, 68.79 ppm. HR ESI MS(+): calcd. for
C10H11BrNaO4 296.9738; found 296.9732. Anal. HPLC (254 nm;
gradient 90% A, 10% D to 50% A, 50% D in 10 min): tR
=
4.366 min.
m.p. 85–87 °C. IR (neat): ν = 3379, 1701, 1462, 1365, 1319, 1234,
˜
1
1190, 1120, 1086, 1064, 1018, 756, 681 cm–1. H NMR (CD3OD):
Supporting Information (see footnote on the first page of this arti-
δ = 7.58–7.68 (m, 2 H), 7.40 (app. t, 1 H), 7.12–25 (m, 1 H), 5.29
(d, J = 4.9 Hz, 1 H), 4.40 (d, J = 4.9 Hz, 1 H), 2.13 (s, 3 H) ppm.
13C NMR (CD3OD): δ = 210.03, 141.69, 133.91, 132.12, 128.78,
128.62, 126.99, 79.59, 73.85, 26.54 ppm. HR ESI MS(+): calcd. for
C10H11BrNaO3 280.9789; found 280.9783. Anal. HPLC (254 nm;
cle): Selected NMR spectra and HPLC traces.
Acknowledgments
This work was supported by the University of Berne and the Swiss
National Science Foundation. We thank Sandra Zima for assist-
ance in preparing the aldol products.
gradient 90% A, 10% D to 50% A, 50% D in 10 min): tR
=
5.585 min.
1,3,4-Trihydroxy-4-(4-nitrophenyl)butan-2-one (10a) as a syn/anti
Mixture:[8] According to the general procedure and starting from
1a (151 mg, 1.0 mmol) and DHA (450 mg, 5.0 mmol), 10a could
be isolated after column chromatography (185 mg, 77%). 1H NMR
(CD3OD): δ = 8.25 (m, 2 H), 7.7 (m, 2 H), 5.3 (d, J = 2.4 Hz, 0.5
H), 5.05 (d, J = 5.8 Hz, 0.5 H), 4.55 (m, 1 H), 4.40 and 4.30 (2br.
d, 1 H) ppm. 13C NMR (DMSO): δ = 211.76, 146.22, 131.09,
128.63, 128.14, 124.66, 123.26, 79.29, 73.76, 66.83 ppm.
[1] For review articles and references, see: a) T. D. Machajewski,
C.-H. Wong, Angew. Chem. Int. Ed. 2000, 39, 1352–1375; b) C.
Palomo, M. Oiarbide, J. M. Garcia, Chem. Eur. J. 2002, 8, 36;
c) S. G. Nelson, Tetrahedron: Asymmetry 1998, 9, 357–389; d)
H. Gröger, E. M. Vogl, M. Shibasaki, Chem. Eur. J. 1998, 4,
1137–1141.
[2] a) B. List, R. A. Lerner, C. F. Barbas III, J. Am. Chem. Soc.
2000, 122, 2395–2396; b) W. Notz, B. List, J. Am. Chem. Soc.
2000, 122, 7386–7387; c) B. List, Tetrahedron 2002, 58, 5573–
5590; d) L. Hoang, S. Bahmanyar, B. List, J. Am. Chem. Soc.
2003, 125, 16–17; e) D. W. C. MacMillan, A. B. Northrup, J.
Am. Chem. Soc. 2002, 124, 6798; f) K. Sakthievel, W. Notz, T.
Bui, C. F. Barbas III, J. Am. Chem. Soc. 2001, 123, 5260–5267.
[3] a) Z. Tang, F. Jiang, L.-T. Yu, X. Cui, L.-Z. Gong, A.-Q. Mi,
Y.-Z. Jiang, Y.-D. Wu, J. Am. Chem. Soc. 2003, 125, 5262–
5263; b) Z. Tang, F. Jiang, X. Cui, L.-Z. Gong, A.-Q. Mi, Y.-Z.
Jiang, Y.-D. Wu, Proc. Natl. Acad. Sci. USA 2004, 101, 5755; c)
H. J. Martin, B. List, Synlett 2003, 1901; d) J. Kofoed, J. Niel-
sen, J.-L. Reymond, Bioorg. Med. Chem. Lett. 2003, 13, 2445.
[4] a) Y. M. A. Yamada, N. Yoshikawa, H. Sasai, M. Shibasaki,
Angew. Chem. Int. Ed. Engl. 1997, 36, 1871–1873; b) N. Yoshi-
kawa, Y. M. A. Yamada, J. Das, M. Sasai, H. Shibasaki, J. Am.
Chem. Soc. 1999, 121, 4168–4178; c) N. Kumagai, S. Matsun-
aga, N. Yoshikawa, T. Ohshima, M. Shibasaki, Org. Lett. 2001,
3, 1539–1542.
1,3,4-Trihydroxy-4-(2-nitrophenyl)butan-2-one (10b): Starting from
1b (151 mg, 1.0 mmol) and DHA (450 mg, 5.0 mmol), 10b was ob-
tained according to the general procedure with the following modi-
fications: the aqueous solution was lyophilized and the crude prod-
uct purified by preparative RP-HPLC to separate the two dia-
stereoisomers. syn-10b: Yield: 103 mg (43%); oil. IR (neat): ν =
˜
3327, 1726, 1523, 1342, 1230, 1053, 717, 631 cm–1. 1H NMR
(CD3OD): δ = 8.0 (m, 2 H), 7.75 (app. t, 1 H), 7.52 (app. t, 1 H),
5.71 (d, J = 2.07 Hz, 1 H), 4.66 (s, 2 H), 4.48 (d, J = 2.07 Hz, 1 H)
ppm. 13C NMR (CD3OD): δ = 212.61, 149.41, 138.80, 134.38,
132.09, 129.82, 125.45, 79.80, 71.00, 68.24 ppm. HR ESI MS(+):
calcd. for C10H11NNaO6 264.0484; found 264.0486. Anal. HPLC
(254 nm; gradient 90% A, 10% D to 50% A, 50% D in 10 min):
tR = 3.096 min. anti-10b: Yield: 91 mg (38%); yellowish solid, m.p.
58–61 °C. IR (neat): ν = 3271, 1724, 1529, 1040, 1082, 834, 793,
˜
732 cm–1. 1H NMR (CD3OD): δ = 7.83 (d, J = 7.16 Hz, 1 H), 7.75
Eur. J. Org. Chem. 2005, 5268–5276
© 2005 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
www.eurjoc.org
5275